U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C6H14N2O2
Molecular Weight 146.1876
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LYSINE

SMILES

NCCCC[C@H](N)C(O)=O

InChI

InChIKey=KDXKERNSBIXSRK-YFKPBYRVSA-N
InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m0/s1

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.drugs.com/npp/lysine.html | https://www.ncbi.nlm.nih.gov/pubmed/26252373

Lysing is an essential basic amino-acid encoded by codone AAA and AAG, and used in the biosynthesis of proteins. The daily requirement for lysine is 38 mg/kg body weight. The most rich source of lysine is fish, beef, chicken. In a clinical study lysine supplements was found to be an effective for reduction of occurrence, severity and healing time for recurrent HSV infection, however Cochrane Review concluded that the evidence is insufficient. Lysine was investigated for improving anxiety, ameliorating angina prectoris. Lysine acetylsalicylate has been used to treat pain and to detoxify the body after heroin use. Lysine clonixinate has been used for its analgesic properties for the treatment of migraine headaches and other painful conditions. However, limited clinical trials exist for these conditions.

Originator

Curator's Comment: Lysine was first isolated from casein (a milk phosphoprotein) in 1889 by the German dentist Heinrich Drechsel

Approval Year

Targets

Targets

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
L-LYSINE MONOHYDRATE

Approved Use

Lysine has been studied for the prevention and treatment of herpes infections and cold sores.
Primary
L-LYSINE MONOHYDRATE

Approved Use

Lysine supplements may relieve effort-related angina pectoris.
Primary
L-LYSINE MONOHYDRATE

Approved Use

Lysine increases the intestinal absorption and reduces the renal elimination of calcium.
Primary
L-LYSINE MONOHYDRATE

Approved Use

Lysine is believed to exert anxiolytic effects by acting as a partial serotonin receptor 4 antagonist and as a partial benzodiazepine agonist
Palliative
L-LYSINE MONOHYDRATE

Approved Use

Lysine acetylsalicylate has been used to detoxify the body after heroin use.
Primary
NEOPROFEN

Approved Use

NeoProfen is indicated to close a clinically significant patent ductus arteriosus (PDA) in premature infants weighing between 500 and 1500 g, who are no more than 32 weeks gestational age when usual medical management (e.g., fluid restriction, diuretics, respiratory support, etc.) is ineffective. The clinical trial was conducted among infants with an asymptomatic PDA. However, the consequences beyond 8 weeks after treatment have not been evaluated; therefore, treatment should be reserved for infants with clear evidence of a clinically significant PDA.

Launch Date

2006
PubMed

PubMed

TitleDatePubMed
The antioxidant system beta-D(+) glucose-glucose oxidase-catalase: tests for pyrogenicity and antigenicity.
2001
The fermentative production of L-lysine as an animal feed additive.
2001 Apr
Effect of the degree of fatty acid unsaturation of rat heart mitochondria on their rates of H2O2 production and lipid and protein oxidative damage.
2001 Apr 15
The number of morphological synapses between neurons does not predict the strength of their physiological synaptic interactions: a study of dendrites in the nematode Ascaris suum.
2001 Apr 16
Properties of microtubules assembled from mammalian tubulin synthesized in Escherichia coli.
2001 Apr 17
Peflin and ALG-2, members of the penta-EF-hand protein family, form a heterodimer that dissociates in a Ca2+-dependent manner.
2001 Apr 27
Biochemical and functional characterization of a molecule expressed by a subset of thymic medullary epithelial cells.
2001 Feb
Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease.
2001 Feb
Hydrolysed protein accelerates the gastrointestinal transport of formula in preterm infants.
2001 Feb
Combination of HPLC and solid-phase binding assay for isolation and purification of MHC class I and associated peptides using a bladder tumour cell line.
2001 Feb
Affinity purification of Csk protein tyrosine kinase based on its catalytic requirement for divalent metal cations.
2001 Feb
Characterization of the lipopolysaccharide of Yersinia pestis.
2001 Feb
Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1.
2001 Feb
Increased L-arginine uptake and inducible nitric oxide synthase activity in aortas of rats with heart failure.
2001 Feb
The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.
2001 Feb
Identification of a candidate integrin-fraction associated with the activated form of the PDGF-receptor.
2001 Feb 23
Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein.
2001 Feb 6
Uptake and accumulation of exogenous docosahexaenoic acid by Chlorella.
2001 Jan
Endotoxemia and acute-phase proteins in major abdominal surgery.
2001 Jan
Influence of lysates of the salivary glands of Lutzomyia longipalpis on the development of a Leishmania-major-like parasite in the skin of the golden hamster.
2001 Jan
ESR detection of intraphagosomal superoxide in polymorphonuclear leukocytes using 5-(diethoxyphosphoryl)-5-methyl-l-pyrroline-N-oxide.
2001 Jan
Increased stability of nucleophosmin/B23 in anti-apoptotic effect of ras during serum deprivation.
2001 Jan
A Mycobacterium smegmatis gyrase B specific monoclonal antibody reveals association of gyrase A and B subunits in the cell.
2001 Jan 1
Mechanism of release of urinary Tamm-Horsfall glycoprotein from the kidney GPI-anchored counterpart.
2001 Jan 12
Acceleration of thrombomodulin gene transcription by retinoic acid: retinoic acid receptors and Sp1 regulate the promoter activity through interactions with two different sequences in the 5'-flanking region of human gene.
2001 Jan 26
Hsp90 regulates p50(cdc37) function during the biogenesis of the activeconformation of the heme-regulated eIF2 alpha kinase.
2001 Jan 5
Purification of recombinant green fluorescent protein using chromatofocusing with a pH gradient composed of multiple stepwise fronts.
2001 Jan-Feb
The function of interdomain interactions in controlling nucleotide exchange rates in transducin.
2001 Jun 29
Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.
2001 Mar
Inositol phosphates from barley low-phytate grain mutants analysed by metal-dye detection HPLC and NMR.
2001 Mar 1
Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells.
2001 Mar 15
High pressure increases bactericidal activity and spectrum of lactoferrin, lactoferricin and nisin.
2001 Mar 20
Inhibition of cytosolic phospholipase A2 by annexin I. Specific interaction model and mapping of the interaction site.
2001 May 11
CYP2A6*6, a novel polymorphism in cytochrome p450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity.
2001 May 25
The heme-regulated eukaryotic initiation factor 2alpha kinase. A potential regulatory target for control of protein synthesis by diffusible gases.
2001 May 4
Patents

Sample Use Guides

In Vivo Use Guide
Lysin is an essential amino-acid. The daily requirement for lysine is 38 mg/kg body weight. The most rich source of lysine is fish, beef, chicken.
Route of Administration: Oral
In the in vitro study of herpes simplex virus (HSV) growth in tissue culture, arginine deficiency suppressed HSV growth. Maximum herpes growth (as measured by plaques counting) was observed in flasks, containing 10-20 ug/ml of arginine. The addition of 50 ug/ml of lysine to the flasks containing 2.5 and 5.0 ug/ml of arginine reduced the number of viable plaque-forming units (PFU) from 3300 and 48800 to less than 10.
Name Type Language
LYSINE
HSDB   II   INCI   INN   MART.   MI   USAN   VANDF   WHO-DD  
INN   USAN   INCI  
Official Name English
LYSINE [MI]
Common Name English
(+)-S-LYSINE
Common Name English
Lysine [WHO-DD]
Common Name English
L-LYSINE
FHFI  
Systematic Name English
LYSINE [HSDB]
Common Name English
LYSINE [MART.]
Common Name English
LYSINE [USAN]
Common Name English
L-LYSINE [FHFI]
Common Name English
LYSINE [VANDF]
Common Name English
LYSINE [II]
Common Name English
LYSINE [INCI]
Common Name English
TYROSINE IMPURITY B [EP IMPURITY]
Common Name English
lysine [INN]
Common Name English
Classification Tree Code System Code
LOINC 32256-0
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 56955-8
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 22651-4
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 15140-7
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
WHO-VATC QB05XB03
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 13375-1
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 2587-4
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 13769-5
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 2586-6
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 47689-5
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 20650-8
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 47693-7
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 47694-5
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
CFR 21 CFR 172.320
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 22713-2
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 47692-9
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 25952-3
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 47695-2
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
WHO-ATC B05XB03
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 44335-8
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 2585-8
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 30048-3
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 13404-9
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 15136-5
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 55935-1
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 88018-7
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
DSLD 172 (Number of products:1388)
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 27333-4
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
WHO-VATC QA12AA09
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 17230-4
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 27107-2
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 25464-9
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
JECFA EVALUATION 1439
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 32255-2
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 2584-1
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 22679-5
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
CFR 21 CFR 310.537
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 27304-5
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 25953-1
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 47690-3
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
LOINC 47691-1
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
NCI_THESAURUS C68442
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
Code System Code Type Description
HSDB
2108
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
INN
6166
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
DRUG BANK
DB00123
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
MERCK INDEX
m6967
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY Merck Index
EVMPD
SUB36688
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
ECHA (EC/EINECS)
200-294-2
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
CHEBI
133538
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
JECFA MONOGRAPH
1427
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
EVMPD
SUB08629MIG
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
DAILYMED
K3Z4F929H6
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
SMS_ID
100000091077
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
PUBCHEM
5962
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
EPA CompTox
DTXSID6023232
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
CAS
56-87-1
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
FDA UNII
K3Z4F929H6
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
CHEBI
18019
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
ChEMBL
CHEMBL8085
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
NCI_THESAURUS
C1505
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
CONCEPT Dietary Supplement
DRUG CENTRAL
1622
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
CHEBI
29967
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
NCI_THESAURUS
C29171
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
WIKIPEDIA
LYSINE
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
RXCUI
6536
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY RxNorm
CHEBI
32551
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
MESH
D008239
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY
CHEBI
25094
Created by admin on Fri Dec 15 15:00:58 GMT 2023 , Edited by admin on Fri Dec 15 15:00:58 GMT 2023
PRIMARY